Nitric oxide for preventing pre-eclampsia and its complications (Q24245090)

https://api.crossref.org/works/10.1002%2F14651858.CD006490

The effect of a nitric oxide donor on Doppler flow velocity waveforms in the uterine artery during the first trimester of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Effect of L-arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Effects of acute L-arginine infusion on non-stress test in hypertensive pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

L-Arginine treatment for asymmetric fetal growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Interventions for preventing pre-eclampsia and its consequences: generic protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Effects of nitroglycerin on the uterine and umbilical circulation in severe preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Nitric oxide: an endogenous modulator of leukocyte adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Nitric oxide dysfunction in the pathophysiology of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Placental nitric oxide synthase (NOS) activity and nitric oxide (NO) production in normal pregnancy, pre-eclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

Intravenous L-Arginine is a new anti-hypertensive agent forr pregnant women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

The role of nitric oxide in the pathogenesis of preeclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

Evaluation of nitric oxide as a mediator of severe preeclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

Nitric oxide in preeclampsia: lack of evidence for decreased production

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

The effect of nitric oxide on uterine and umbilical artery flow velocity waveform in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: implications for oxidative stress

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

The effect of isosorbide dinitrate on placental blood flow and maternal blood pressure in women with pregnancy induced hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

Nitrovasodilators--will they be useful in lowering uterine artery resistance in pre-eclampsia and intrauterine growth restriction?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

L-Arginine Supplementation in Patients with Gestational Hypertension: A Pilot Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

Effect ofl-arginine on blood pressure in pregnancy-induced hypertension: A randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

PLATELET RESPONSIVENESS TOL-ARGININE IN HYPERTENSIVE DISORDERS OF PREGNANCY

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

Nitric oxide donors stimulate prostaglandin F2alpha and inhibit thromboxane B2 production in the human cervix during the first trimester of pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

Nitric oxide synthase activities in placental tissue from normotensive, pre-eclamptic and growth retarded pregnancies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

Effects of oral L-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

24-Hour Ambulatory Blood Pressure Monitoring: A Comparison Between Transdermal Glyceryl-Trinitrate and Oral Nifedipine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006490

7 January 2021

10.1002/14651858.CD006490

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1122508

OpenCitations bibliographic resource ID

1122508

1 reference